WATSON 862 (Hydrochlorothiazide and lisinopril 25 mg / 20 mg)

Pill imprint WATSON 862 has been identified as Hydrochlorothiazide and lisinopril 25 mg / 20 mg.

Hydrochlorothiazide/lisinopril is used in the treatment of high blood pressure; heart failure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/lisinopril 25 mg / 20 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WATSON 862

Hydrochlorothiazide and lisinopril 25 mg / 20 mg WATSON 862
Hydrochlorothiazide and lisinopril 25 mg / 20 mg WATSON 862
Hydrochlorothiazide and lisinopril 25 mg / 20 mg WATSON 862
Hydrochlorothiazide and lisinopril
Imprint:
WATSON 862
Strength:
25 mg / 20 mg
Color:
Pink
Size:
10.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Antihypertensive combinations
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-0862
Inactive Ingredients:
silicon dioxide
calcium phosphate dihydrate dibasic
FD&C Red No. 40
magnesium stearate
mannitol
corn starch
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
49999-0321 Lake Erie Medical and Surgical Supply (repackager)
21695-0735 Rebel Distributors Corp (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)